Suppr超能文献

参与亨特结果调查的II型黏多糖贮积症(亨特综合征)患者的骨科表现。

Orthopedic manifestations in patients with mucopolysaccharidosis type II (Hunter syndrome) enrolled in the Hunter Outcome Survey.

作者信息

Link Bianca, de Camargo Pinto Louise Lapagesse, Giugliani Roberto, Wraith James Edmond, Guffon Nathalie, Eich Elke, Beck Michael

机构信息

Children's Hospital, Johannes-Gutenberg University, Mainz, Germany;

出版信息

Orthop Rev (Pavia). 2010 Sep 23;2(2):e16. doi: 10.4081/or.2010.e16.

Abstract

Mucopolysaccharidosis type II (MPS II or Hunter syndrome) is a rare, inherited disorder caused by deficiency of the lysosomal enzyme iduronate-2-sulfatase. As a result of this deficiency, glycosaminoglycans accumulate in lysosomes in many tissues, leading to progressive multisystemic disease. The cardiopulmonary and neurological problems associated with MPS II have received considerable attention. Orthopedic manifestations are common but not as well characterized. This study aimed to characterize the prevalence and severity of orthopedic manifestations of MPS II and to determine the relationship of these signs and symptoms with cardiovascular, pulmonary and central nervous system involvement.Orthopedic manifestations of MPS II were studied using cross-sectional data from the Hunter Outcome Survey (HOS). The HOS is a global, physician-led, multicenter observational database that collects information on the natural history of MPS II and the long-term safety and effectiveness of enzyme replacement therapy.As of January 2009, the HOS contained baseline data on joint range of motion in 124 males with MPS II. In total, 79% of patients had skeletal manifestations (median onset, 3.5 years) and 25% had abnormal gait (median onset, 5.4 years). Joint range of motion was restricted for all joints assessed (elbow, shoulder, hip, knee and ankle). Extension was the most severely affected movement: the exception to this was the shoulder. Surgery for orthopedic problems was rare. The presence of orthopedic manifestations was associated with the presence of central nervous system and pulmonary involvement, but not so clearly with cardiovascular involvement.Orthopedic interventions should be considered on an individual-patient basis. Although some orthopedic manifestations associated with MPS II may be managed routinely, a good knowledge of other concurrent organ system involvement is essential. A multidisciplinary approach is required.

摘要

II型黏多糖贮积症(MPS II或亨特综合征)是一种罕见的遗传性疾病,由溶酶体酶艾杜糖醛酸-2-硫酸酯酶缺乏引起。由于这种缺乏,糖胺聚糖在许多组织的溶酶体中积累,导致进行性多系统疾病。与MPS II相关的心肺和神经问题受到了相当多的关注。骨科表现很常见,但特征不那么明显。本研究旨在描述MPS II骨科表现的患病率和严重程度,并确定这些体征和症状与心血管、肺和中枢神经系统受累之间的关系。

使用来自亨特结果调查(HOS)的横断面数据研究了MPS II的骨科表现。HOS是一个由医生主导的全球多中心观察数据库,收集有关MPS II自然史以及酶替代疗法长期安全性和有效性的信息。

截至2009年1月,HOS包含124名患有MPS II的男性的关节活动范围基线数据。总体而言,79%的患者有骨骼表现(中位发病年龄,3.5岁),25%的患者步态异常(中位发病年龄,5.4岁)。所有评估的关节(肘部、肩部、髋部、膝部和踝部)的关节活动范围均受限。伸展是受影响最严重的动作:肩部除外。因骨科问题进行手术的情况很少见。骨科表现的存在与中枢神经系统和肺部受累有关,但与心血管受累的关系不那么明显。

骨科干预应根据个体患者情况考虑。虽然一些与MPS II相关的骨科表现可能可以常规处理,但了解其他并发器官系统的受累情况至关重要。需要采取多学科方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f6f/3143973/32b68091a050/or-2010-2-e16-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验